1. Health technology

  2. •

    Medical specialties
Alcon AG

Alcon AG

56.28
EUR
-0.66
(-1.16%)
1.43EPS
45.97P/E
32.19BMarket Cap
Alcon AG
MIL:1ALC
(Euronext Milan)

Recent

price

56.28

P/E

ratio

45.97

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CHF
13.74
13.53
14.38
14.87
12.36
15.43
16.39
16.13
18.19
16.71
17.2
Revenue per Share
-0.35
0.51
-0.46
-1.3
-0.96
0.7
0.63
1.66
1.87
1.57
1.32
Basic EPS, GAAP
1.54
1.44
0.86
0.48
0.46
0.31
0.89
0.92
2.58
2.58
2.57
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.1
0.19
0.2
0.24
0.27
- -
Dividend per Share
- -
45.89
45.52
38.23
34.04
35.84
37.1
35.17
39.53
- -
36.23
Book Value per Share
- -
5.17
6.15
0.33
1.48
2.95
2
4.5
7.37
- -
6.54
Tangible Book Value per Share
489
489
489
488
489
490
491
493
494
493
491
Basic Weighted Avg Shares
6,713
6,614
7,029
7,260
6,045
7,563
8,055
7,953
8,991
8,242
8,451
Sales/Revenue/Turnover
0.15
-1.13
-3.47
-2.49
-7.05
7
7.71
10.99
14.26
13.08
11.13
Operating Margin (%)
1,312
1,271
1,594
1,378
1,436
1,112
1,038
1,027
1,114
1,058
1,070
Depreciation Expense
-173
249
-223
-634
-470
343
310
819
923
777
651
Net Income, GAAP
- -
- -
- -
- -
- -
10.05
27.65
- -
18.95
15.52
16.94
Effective Tax Rate (%)
-2.58
3.77
-3.17
-8.74
-7.77
4.54
3.84
10.3
10.27
9.42
7.7
Profit Margin (%)
- -
1,469
1,480
1,872
2,414
2,658
2,269
2,733
3,657
2,694
2,887
Working Capital
- -
82
87
3,382
3,772
3,927
4,528
4,215
389
340
3,677
LT Debt
- -
22,424
22,245
18,666
16,651
17,565
18,183
17,347
19,552
- -
17,671
Total Equity
- -
- -
- -
- -
- -
2.23
2
- -
4.95
- -
3.38
Return on Invested Capital (%)
- -
- -
- -
- -
- -
2.09
1.79
- -
5.1
- -
3.43
Return on Capital (%)
- -
- -
-1
-3.1
-2.66
2
1.73
4.61
5.01
- -
3.51
Return on Common Equity (%)

Capital Structure

CHF

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
515
- -
517
LT Borrowings
3,311
- -
3,319
LT Finance Leases
340
340
358
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
491
487
488
Market Capitalization
28,889
30,819
29,707

Working Capital

CHF

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5,037
5,110
5,286
Cash, Cash Equivalents & STI
1,191
- -
1,325
Accounts Receivable, Net
1,518
- -
1,582
Inventories
1,935
1,895
1,947
Total Current Liabilities
2,378
2,416
2,398
Payables & Accruals
868
- -
900
ST Debt
515
- -
517
Deferred Revenue
- -
67
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
68.45%
-0.18%
Net Income, GAAP
- -
-4.26%
-15.91%
Sales/Revenue/Turnover
- -
7.01%
-8.34%
Total Cash Common Dividend
- -
- -
11.53%

Quarterly Revenue

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,216
2,242
2,074
2,270
8,991
2025
2,186
2,058
2,079
2,154
8,242
2026
2,161
- -
- -
- -
- -

Quarterly Earnings Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.45
0.41
0.45
0.52
1.87
2025
0.62
0.28
0.38
0.35
1.57
2026
0.31
- -
- -
- -
- -

Quarterly Dividends Per Share

CHF

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.24
2025
- -
- -
- -
- -
0.27
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business